m3-muscarinic antibodies

  1. forestglip

    Trial Report Effect on QoL of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of ME/CFS Patients, 2025, Oesch-Regeni

    This is the abstract of the preprint. See post #3 for peer-reviewed paper. ------------------------------------------------------ Effect on Quality of Life of Therapeutic Plasmapheresis in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic...
Back
Top Bottom